Skip to main content

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring


via The Scientist RSS https://ift.tt/Fze2Ipt Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and the secukinumab–interleukin 17A (IL-17A) drug-target complex. https://ift.tt/RXCpuDg July 21, 2022 at 09:47PM
Labels:

Comments

Post a Comment

Popular posts from this blog

Doubts Raised Over Whether Mice Can Truly Inherit Immunity

via The Scientist RSS https://ift.tt/3fXmHT5 An independent lab fails to replicate results suggesting mammals exposed to pathogens could pass on immunological protections through epigenetic mechanisms. https://ift.tt/eA8V8J January 27, 2022 at 12:10AM
Post a Comment
Read more

A New Smartphone Application Improves Memory Recall in Older Adults

via The Scientist RSS https://ift.tt/HF8yhqs Neuroscientists developed and tested a promising mobile app that mitigates age-related memory decline. https://ift.tt/kpa8Dct May 08, 2023 at 11:26PM
Post a Comment
Read more

Alu Leap May Explain Why Apes Don't Have Tails

via The Scientist RSS https://ift.tt/3u3quo5 A transposable element that jumped into the TBXT gene, which is linked to tail morphology, appears to be to blame for our missing appendage. https://ift.tt/eA8V8J September 23, 2021 at 06:28PM
Post a Comment
Read more